A prospective evaluation of the combined helical tomotherapy and chemotherapy in pediatric patients with unresectable rhabdomyosarcoma of the temporal bone
Zhang X, Ma K, Wang J, Wu W, Ma L, Huang D | Cell Biochem Biophys | 2014
Clinical implementation of radiosurgery using the Helical TomoTherapy unit
Saw CB, Gillette C, Peters CA, Koutcher L | Med Dosim | 2018
Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm
Koide Y, Tomita N, Adachi S, Tanaka H, Tachibana H, Kodaira T | Nagoya J Med Sci | 2019
Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy
Arpa D, Parisi E, Ghigi G, Savini A, Colangione SP, Tontini L, Pieri M, Foca F, Polico R, Tesei A, Sarnelli A, Romeo A | Sci Rep | 2020
Comparison of Absolute Dose Achievable Between Helical Tomotherapy and RapidArc in Total Dura Mater Irradiation for Child Cancer
Wenzhao Sun, Jun Zhang, Yixuan Wang, Meining Chen, Jianli Wang, Li Chen, Lixia Lu, Xiaowu Deng. | Technol Cancer Res Treat | 2022
Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis
Pinzi V, Orsi C, Marchetti M, Milanesi IM, Bianchi LC, DiMeco F, Cuccarini V, Farinotti M, Ferroli P, Finocchiaro G, Franzini A, Fumagalli M, Silvani A, Fariselli L | Neurol Sci | 2015
CyberKnife Stereotactic Radiosurgery for Atypical and Malignant Meningiomas
Zhang M, Ho AL, D’Astous M, Pendharkar AV, Choi CY, Thompson PA, Tayag AT, Soltys SG, Gibbs IC, Chang SD | World Neurosurg | 2016
Long-Term Outcomes Following Conventionally Fractionated Stereotactic Boost for High-Grade Gliomas in Close Proximity to Critical Organs at Risk
Repka MC, Lei S, Campbell L, Suy S, Voyadzis JM, Kalhorn C, McGrail K, Jean W, Subramaniam DS, Lischalk JW, Collins SP, Collins BT | Front Oncol | 2018
CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis
De Maria L, Terzi di Bergamo L, Conti A, Hayashi K, Pinzi V, Murai T, Lanciano R, Burneikiene S, Buglione di Monale M, Magrini SM, Fontanella MM | Front Oncol | 2021
Is the CyberKnife © radiosurgery system effective and safe for patients? An umbrella review of the evidence
Yifan Cheng, Yifei Lin, Youlin Long, Liang Du, Rui Chen, Tengyue Hu, Qiong Guo, Ga Liao, Jin Huang | Future Ocol | 2022
Treatment of Residual, Recurrent, or Metastatic Intracranial Hemangiopericytomas With Stereotactic Radiotherapy Using CyberKnife
Huang L, Bai J, Zhang Y, Cui Z, Zhang Z, Li J, Wang J, Yu X, Ling Z, Qu B, Pan L | Front Oncol | 2021
Image-Guided Robotic Radiosurgery for the Management of Spinal Ependymomas
Ehret F, Kufeld M, Fürweger C, Haidenberger A, Windisch P, Senger C, Kord M, Träger M, Kaul D, Schichor C, Tonn JC, Muacevic A | Front Oncol | 2021
The Stanford stereotactic radiosurgery experience on 7000 patients over 2 decades (1999-2018): looking far beyond the scalpel
Fatima N, Meola A, Ding VY, Pollom E, Soltys SG, Chuang CF, Shahsavari N, Hancock SL, Gibbs IC, Adler JR, Chang SD.J | Neurosurg | 2021
PO-1158: Re-irradiation with Stereotactic Radiotherapy for Recurrent High Grade Glial Tumors
Ela Delikgoz Soykut, Eylem Odabasi, Nilgun Sahin | ESTRO | 2022
Adaptive Planning Using PreciseART for Glioblastoma Patient Wearing Tumor Treating Fields Device
Y Qin, R Tobias, R Foster, M Pankuch | AAPM | 2022
Dosimetric Evaluation of the Treatment Goals Effectiveness of VMAT / Cyber Knife Versus IMPT When LET / Variable RBE Are Taken Into Consideration for Brain Tumors
H Kamal Sayed, Q Xu, J Fan | AAPM | 2022
